International Publications Spotlight MJNA’s Influence on U.N.’s Global CBD Policy Announcement

Following the WHO’s announcement of its stance that CBD not be considered a drug, several news reports covering the event highlighted MJNA’s role in the organization’s decision.

Several international news publications covering last week’s World Health Organization announcement of its recommendation that cannabidiol (CBD) not be subject to international drug scheduling specifically highlighted the impact of Medical Marijuana, Inc. Executive Raul Elizalde.

Raul Addresses WHO Committee about CBD at United Nations

Raul, President of Medical Marijuana, Inc. subsidiary HempMeds® Mexico, was invited to speak about CBD at the WHO’s Thirty-Ninth meeting of the Expert Committee on Drug Dependence in Geneva, Switzerland in November. The ECDD was reevaluating its international regulations of 16 substances, including CBD, a cannabis-derived, non-psychoactive compound that interacts with our naturally occurring systems.

On behalf of MJNA’s family of companies, Raul spoke to the ECDD about the benefits of CBD and encouraged the special committee to classify the non-psychoactive compound as a nutritional supplement and food rather than a drug. The special committee’s recommendation regarding the regulation of CBD is likely to have positive worldwide implications on legal access.

MJNA’s #RaulWHO campaign followed Raul during his journey to Geneva. Through the #RaulWHO page, those concerned about the future of CBD could keep up with regular announcements and personal streaming video updates from Raul.

Raul’s Impact on CBD Decision Garners International News Coverage

Raul’s incredible efforts and his influence on the WHO special committee’s recommendation were covered in international media outlets such as the following:

  • The Daily Mail
  • WestWord newspapers
  • The Georgia Straight Vancouver
  • New Zealand Herald
  • Metro UK
  • Bustle
  • Newburgh Gazette
  • TeleSur TV

“We couldn’t be prouder to have Raúl representing the Medical Marijuana, Inc. portfolio of companies and to have our mission of increasing access to CBD featured in coverage on such prominent media outlets,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus.

“We believe that Raúl had a significant impact on the World Health Organization’s recommendation not to schedule CBD and we’re thankful that the media continues to view him as an important cannabis industry icon. Medical Marijuana, Inc. continues to be a leader for the industry, and the future is very bright indeed.”

Learn More about MJNA and CBD

Read more about CBD through our education page, or keep up with Medical Marijuana, Inc.’s entire portfolio of companies on our news feed.